Inventor · disambiguated record
Per-Ola Freskgard
Also filed as: FRESKGAARD PER-OLA · FRESKGARD PER-OLA · FRESKGÅRD PER-OLA
25 granted patents·28 pending applications·204 citations·filing 2002–2025
96Inventor score
Top patents by PatentIndex Score
53 records- 0195US10287576B2Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2016·Granted May 14, 2019·19 cites·22 claims
- 0295US8206901B2Method for the synthesis of a bifunctional complexFRESKGARD PER-OLA·Filed 2003·Granted Jun 26, 2012·52 cites·193 claims
- 0393US10662239B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2017·Granted May 26, 2020·9 cites·12 claims
- 0493US7727713B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2002·Granted Jun 1, 2010·39 cites·241 claims
- 0592US11286297B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2020·Granted Mar 29, 2022·4 cites·17 claims
- 0692US10077440B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2015·Granted Sep 18, 2018·5 cites·52 claims
- 0792US9284600B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2013·Granted Mar 15, 2016·9 cites·18 claims
- 0892US9109248B2Method for the synthesis of a bifunctional complexFRESKGARD PER-OLA·Filed 2012·Granted Aug 18, 2015·11 cites·141 claims
- 0991US9487775B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2015·Granted Nov 8, 2016·6 cites·71 claims
- 1090US9834598B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2013·Granted Dec 5, 2017·9 cites·7 claims
- 1188US9574189B2Enzymatic encoding methods for efficient synthesis of large librariesFRANCH THOMAS·Filed 2006·Granted Feb 21, 2017·19 cites·38 claims
- 1287US12344664B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2024·Granted Jul 1, 2025·0 cites·20 claims
- 1385US10669538B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2016·Granted Jun 2, 2020·2 cites·106 claims
- 1485US8932992B2Templated molecules and methods for using such moleculesPEDERSEN HENRIK·Filed 2008·Granted Jan 13, 2015·6 cites·11 claims
- 1583US2025304670A1Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1680US9993564B2Blood brain barrier shuttleHOFFMANN LA ROCHE·Filed 2016·Granted Jun 12, 2018·8 cites·12 claims
- 1778US12098191B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2022·Granted Sep 24, 2024·0 cites·12 claims
- 1878US9096951B2Method for producing second-generation libraryFRESKGARD PER-OLA·Filed 2011·Granted Aug 4, 2015·2 cites·12 claims
- 1976US10208087B2PeptidesHOFFMANN LA ROCHE·Filed 2015·Granted Feb 19, 2019·2 cites·6 claims
- 2072US11001835B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2018·Granted May 11, 2021·0 cites·32 claims
- 2169US11702652B2Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2020·Granted Jul 18, 2023·0 cites·21 claims
- 2268US2025034538A1Fusion proteins targeted to the central nervous systemHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2368US2025051429A1Anti-a-beta protein antibodies, methods and uses thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2467US11965209B2Method for obtaining structural information concerning an encoded molecule and method for selecting compoundsNUEVOLUTION AS·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 2567US11118215B2Method for obtaining structural information concerning an encoded molecule and method for selecting compoundsTHISTED THOMAS·Filed 2004·Granted Sep 14, 2021·2 cites·141 claims
- 2667US2019330618A1Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2019·Application pending·0 cites
- 2767US2022211865A1Reduction of application-related side reaction of a therapeutic antibodyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2865US9688980B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2014·Granted Jun 27, 2017·0 cites·14 claims
- 2963US2005221384A1Combinatorial libraries of monomer domainsMAXYGEN INC·Filed 2004·Application pending·0 cites
- 3062US2007026397A1Method for producing second-generation libraryNUEVOLUTION AS·Filed 2004·Application pending·0 cites
- 3160US2005089932A1Novel proteins with targeted bindingAVIDIA RES INST·Filed 2004·Application pending·0 cites
- 3259US2018344869A1Reduction of application-related side reaction of a therapeutic antibodyHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3358US2020289665A1Reduction of application-related side reaction of a therapeutic antibodyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3458US2024141027A1Bispecific binding moleculeBIOARCTIC AB·Filed 2022·Application pending·0 cites
- 3554US2005053973A1Novel proteins with targeted bindingAVIDIA RES INST·Filed 2004·Application pending·0 cites
- 3653US2006286603A1Combinatorial libraries of monomer domainsAVIDIA RES INST·Filed 2006·Application pending·0 cites
- 3749US2019276530A1Blood brain barrier shuttleHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3848US2006234231A1Microarrays displaying encoded moleculesNUEVOLUTION AS·Filed 2003·Application pending·0 cites
- 3948US2006269920A1Method for obtaining structural information about an encoded moleculeNUEVOLUTION AS·Filed 2004·Application pending·0 cites
- 4047US2025388664A1Bispecific binding moleculeBIOARCTIC AB·Filed 2025·Application pending·0 cites
- 4146US2004175756A1Methods for using combinatorial libraries of monomer domainsAVIDIA RES INST·Filed 2003·Application pending·0 cites
- 4245US2016168253A1Therapeutic fusion proteinHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4344US10683329B2Dual-site BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Jun 16, 2020·0 cites·15 claims
- 4444US2008242590A1New Method 706ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 4543US2012282176A1Method and Constructs for the pH Dependent Passage of the Blood-brain-barrierBOHRMANN BERND·Filed 2012·Application pending·0 cites
- 4643US2005048512A1Combinatorial libraries of monomer domainsAVIDIA RES INST·Filed 2003·Application pending·0 cites
- 4742US2017174776A1METHOD AND CONSTRUCTS FOR THE pH DEPENDENT PASSAGE OF THE BLOOD-BRAIN-BARRIERROCHE GLYCART AG·Filed 2015·Application pending·0 cites
- 4841US10947272B2BACE1 inhibitor peptidesHOFFMANN LA ROCHE·Filed 2016·Granted Mar 16, 2021·0 cites·11 claims
- 4941US2008274096A1Fusion Proteins Having a Modulated Half-Life in PlasmaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 5038US2015322149A1Blood brain barrier shuttleHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →